These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 24504579)

  • 1. Nerve decompression after diabetic foot ulceration may protect against recurrence: a 3-year controlled, prospective analysis.
    Nickerson DS; Rader AJ
    J Am Podiatr Med Assoc; 2014; 104(1):66-70. PubMed ID: 24504579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Illustration of Cost Saving Implications of Lower Extremity Nerve Decompression to Prevent Recurrence of Diabetic Foot Ulceration.
    Rankin TM; Miller JD; Gruessner AC; Nickerson DS
    J Diabetes Sci Technol; 2015 Jul; 9(4):873-80. PubMed ID: 26055081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low long-term risk of foot ulcer recurrence after nerve decompression in a diabetes neuropathy cohort.
    Nickerson DS; Rader AJ
    J Am Podiatr Med Assoc; 2013; 103(5):380-6. PubMed ID: 24072366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low recurrence rate of diabetic foot ulcer after nerve decompression.
    Nickerson DS
    J Am Podiatr Med Assoc; 2010; 100(2):111-5. PubMed ID: 20237362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconsidering nerve decompression: an overlooked opportunity to limit diabetic foot ulcer recurrence and amputation.
    Nickerson DS
    J Diabetes Sci Technol; 2013 Sep; 7(5):1195-201. PubMed ID: 24124946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Objective Evidence That Nerve Decompression Surgery Reduces Neuropathic DFU Recurrence Risk to Less than 5.
    Nickerson DS; Yamasaki DS
    Adv Wound Care (New Rochelle); 2024 Jul; 13(7):363-374. PubMed ID: 38511527
    [No Abstract]   [Full Text] [Related]  

  • 7. Nerve decompression and neuropathy complications in diabetes: Are attitudes discordant with evidence?
    Nickerson DS
    Diabet Foot Ankle; 2017; 8(1):1367209. PubMed ID: 28959382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration.
    O'Meara S; Cullum N; Majid M; Sheldon T
    Health Technol Assess; 2000; 4(21):1-237. PubMed ID: 11074391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower limb biomechanical characteristics of patients with neuropathic diabetic foot ulcers: the diabetes foot ulcer study protocol.
    Fernando ME; Crowther RG; Cunningham M; Lazzarini PA; Sangla KS; Golledge J
    BMC Endocr Disord; 2015 Oct; 15():59. PubMed ID: 26499881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Achilles tendon lengthening on neuropathic plantar ulcers. A randomized clinical trial.
    Mueller MJ; Sinacore DR; Hastings MK; Strube MJ; Johnson JE
    J Bone Joint Surg Am; 2003 Aug; 85(8):1436-45. PubMed ID: 12925622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for recurrence of diabetic foot ulcers: prospective follow-up analysis in the Eurodiale subgroup.
    Dubský M; Jirkovská A; Bem R; Fejfarová V; Skibová J; Schaper NC; Lipsky BA
    Int Wound J; 2013 Oct; 10(5):555-61. PubMed ID: 22712631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropathic plantar forefoot ulcers treated with tendon lengthenings.
    Laborde JM
    Foot Ankle Int; 2008 Apr; 29(4):378-84. PubMed ID: 18442451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale, Science, and Economics of Surgical Nerve Decompression for Diabetic Neuropathy Foot Complications.
    Nickerson DS
    Clin Podiatr Med Surg; 2016 Apr; 33(2):267-82. PubMed ID: 27013417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence rates suggest delayed identification of plantar ulceration for patients in diabetic foot remission.
    Petersen BJ; Bus SA; Rothenberg GM; Linders DR; Lavery LA; Armstrong DG
    BMJ Open Diabetes Res Care; 2020 Sep; 8(1):. PubMed ID: 32998870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors associated with diabetic foot ulcer-free survival in patients with diabetes.
    Yazdanpanah L; Shahbazian H; Nazari I; Hesam S; Ahmadi F; Cheraghian B; Arti HR; Mohammadianinejad SE
    Diabetes Metab Syndr; 2018 Nov; 12(6):1039-1043. PubMed ID: 30168426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ulcer metastasis? Anatomical locations of recurrence for patients in diabetic foot remission.
    Petersen BJ; Rothenberg GM; Lakhani PJ; Zhou M; Linders DR; Bloom JD; Wood KA; Armstrong DG
    J Foot Ankle Res; 2020; 13():1. PubMed ID: 31956341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Our experience of reinnervation of sole in diabetic sensorimotor polyneuropathy: A chance to change the natural history of disease.
    Agarwal P; Sharma D
    J Clin Orthop Trauma; 2021 Jun; 17():25-29. PubMed ID: 33717968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changing the natural history of diabetic neuropathy: incidence of ulcer/amputation in the contralateral limb of patients with a unilateral nerve decompression procedure.
    Aszmann O; Tassler PL; Dellon AL
    Ann Plast Surg; 2004 Dec; 53(6):517-22. PubMed ID: 15602245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient education for preventing diabetic foot ulceration.
    Dorresteijn JA; Kriegsman DM; Assendelft WJ; Valk GD
    Cochrane Database Syst Rev; 2010 May; (5):CD001488. PubMed ID: 20464718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent and other new foot ulcers after healed plantar forefoot diabetic ulcer.
    Örneholm H; Apelqvist J; Larsson J; Eneroth M
    Wound Repair Regen; 2017 Apr; 25(2):309-315. PubMed ID: 28370839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.